Farms.com Home   News

Bird Flu outbreak spreads to dairy cows across 12 states

USDA urged to compensate farmers as milk losses mount

By Farms.com

Wyoming has become the latest state to report a case of bird flu in dairy cows, bringing the total to twelve states grappling with this livestock disease.

The confirmation came from both the Wyoming State Veterinary Laboratory and the U.S. Department of Agriculture’s National Veterinary Services Laboratory.

This outbreak has raised considerable concerns among dairy farmers nationwide, particularly regarding the impact on milk production.

In Iowa, where the virus has also recently been detected, state officials are advocating for USDA intervention to compensate farmers for lost milk production, or the costs involved in culling infected cows.

Highly Pathogenic Avian Influenza, while lethal to birds and less severe in cattle, has already resulted in several deaths among infected cattle across five states.

The broader agricultural community is now under pressure to coordinate efforts to combat the disease effectively and prevent further losses.

Health risks to humans from the bird flu remain low, as evidenced by recent CDC research using ferrets as a model for human infection.

The study highlighted that while the virus transmits efficiently through direct contact among ferrets, it does not spread effectively through respiratory droplets.

This ongoing agricultural dilemma underscores the need for prompt and decisive action to support the farmers affected and to maintain the integrity of the U.S. dairy industry amidst this challenging period.

The agricultural sector’s resilience is being tested, and support from federal agencies like the USDA could be crucial in navigating this crisis.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.